| US to begin intradermal injections of Jynneos, stretching the supply |
| Wednesday, August 10, 2022 11:21 AM |
| The Biden Administration and the Department of Health and Human Services (HHS) have announced that they will begin allowing intradermal injections of Bavarian Nordic's Jynneos monkeypox vaccine, which will allow clinicians to use one-fifth the amount of vaccine per patient and stretch the limited supply in the United States. Read more. |
Daily News
- MMWR Weekly - April 25, 2024
- 1 in 5 US retail milk samples test positive for H5N1 avian flu fragments
- Impaired sense of smell still common 1 year after COVID-19
- Climate change and dentistry: Understanding our impact and opportunities
- Risk of SARS-CoV-2 infection in dental healthcare workers - a systematic review and meta-analysis
Our Sponsors
